# Effect of Rapamycin in Ovarian Aging

> **NCT05836025** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Columbia University** · enrollment: 50 (actual)

## Conditions studied

- Perimenopausal

## Interventions

- **DRUG:** Rapamycin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05836025
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2025-10-21
- **Final completion:** 2026-09
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05836025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05836025, "Effect of Rapamycin in Ovarian Aging". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05836025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*